» Articles » PMID: 20798864

Metformin Improves Insulin Signaling in Obese Rats Via Reduced IKKbeta Action in a Fiber-Type Specific Manner

Overview
Journal J Obes
Publisher Wiley
Specialty Endocrinology
Date 2010 Aug 28
PMID 20798864
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Metformin is a widely used insulin-sensitizing drug, though its mechanisms are not fully understood. Metformin has been shown to activate AMPK in skeletal muscle; however, its effects on the inhibitor of kappaB kinasebeta (IKKbeta) in this same tissue are unknown. The aim of this study was to (1) determine the ability of metformin to attenuate IKKbeta action, (2) determine whether changes in AMPK activity are associated with changes in IKKbeta action in skeletal muscle, and (3) examine whether changes in AMPK and IKKbeta function are consistent with improved insulin signaling. Lean and obese male Zuckers received either vehicle or metformin by oral gavage daily for four weeks (four groups of eight). Proteins were measured in white gastrocnemius (WG), red gastrocnemius (RG), and soleus. AMPK phosphorylation increased (P < .05) in WG in both lean (57%) and obese (106%), and this was supported by an increase in phospho-ACC in WG. Further, metformin increased IkappaBalpha levels in both WG (150%) and RG (67%) of obese rats, indicative of reduced IKKbeta activity (P < .05), and was associated with reduced IRS1-pSer(307) (30%) in the WG of obese rats (P < .02). From these data we conclude that metformin treatment appears to exert an inhibitory influence on skeletal muscle IKKbeta activity, as evidenced by elevated IkappaBalpha levels and reduced IRS1-Ser(307) phosphorylation in a fiber-type specific manner.

Citing Articles

Safety assessment of the ethanolic extract of Gongronema latifolium Benth. leaves: a 90-day oral toxicity study in Sprague Dawley rats.

Al-Hindi B, Yusoff N, Ahmad M, Atangwho I, Asmawi M, Al-Mansoub M BMC Complement Altern Med. 2019; 19(1):152.

PMID: 31253153 PMC: 6599297. DOI: 10.1186/s12906-019-2573-x.


Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1.

Tanokashira D, Kurata E, Fukuokaya W, Kawabe K, Kashiwada M, Takeuchi H FEBS Open Bio. 2018; 8(7):1104-1118.

PMID: 29988567 PMC: 6026705. DOI: 10.1002/2211-5463.12436.


Mitochondria in the middle: exercise preconditioning protection of striated muscle.

Lawler J, Rodriguez D, Hord J J Physiol. 2016; 594(18):5161-83.

PMID: 27060608 PMC: 5023703. DOI: 10.1113/JP270656.


Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability.

Clemmer J, Xiang L, Lu S, Mittwede P, Hester R Microcirculation. 2016; 23(3):221-9.

PMID: 26749564 PMC: 4818684. DOI: 10.1111/micc.12267.


Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats.

Lin C, Tsai J, Chang C, Cheng J, Lin J Drug Des Devel Ther. 2015; 9:4709-17.

PMID: 26316709 PMC: 4544623. DOI: 10.2147/DDDT.S86616.


References
1.
Kim J, Kim Y, Fillmore J, Chen Y, Moore I, Lee J . Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 2001; 108(3):437-46. PMC: 209353. DOI: 10.1172/JCI11559. View

2.
Gray R, Tanner C, Pories W, Macdonald K, Houmard J . Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab. 2002; 284(4):E726-32. DOI: 10.1152/ajpendo.00371.2002. View

3.
Jhun B, Jin Q, Oh Y, Kim S, Kong Y, Cho Y . 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem Biophys Res Commun. 2004; 318(2):372-80. DOI: 10.1016/j.bbrc.2004.04.035. View

4.
Ragheb R, Shanab G, Medhat A, Seoudi D, Adeli K, Fantus I . Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways. Biochem Biophys Res Commun. 2009; 389(2):211-6. PMC: 2981601. DOI: 10.1016/j.bbrc.2009.08.106. View

5.
Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E . Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab. 2001; 86(3):1306-12. DOI: 10.1210/jcem.86.3.7309. View